Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

SARS-CoV-2 escaped natural immunity, raising questions about vaccines and therapies
Emanuele Andreano, Rino Rappuoli
Nature Medicine (2021) Vol. 27, Iss. 5, pp. 759-761
Closed Access | Times Cited: 72

Showing 1-25 of 72 citing articles:

SARS-CoV-2 escape from a highly neutralizing COVID-19 convalescent plasma
Emanuele Andreano, Giulia Piccini, Danilo Licastro, et al.
Proceedings of the National Academy of Sciences (2021) Vol. 118, Iss. 36
Open Access | Times Cited: 361
Reduced sensitivity of infectious SARS-CoV-2 variant B.1.617.2 to monoclonal antibodies and sera from convalescent and vaccinated individuals
Delphine Planas, David Veyer, Artem Baidaliuk, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2021)
Closed Access | Times Cited: 278
Respiratory mucosal delivery of next-generation COVID-19 vaccine provides robust protection against both ancestral and variant strains of SARS-CoV-2
Sam Afkhami, Michael R. D’Agostino, Ali Zhang, et al.
Cell (2022) Vol. 185, Iss. 5, pp. 896-915.e19
Open Access | Times Cited: 267
Evolution of antibody responses up to 13 months after SARS-CoV-2 infection and risk of reinfection
Floriane Gallais, Pierre Gantner, Timothée Bruel, et al.
EBioMedicine (2021) Vol. 71, pp. 103561-103561
Open Access | Times Cited: 213
The success of SARS-CoV-2 vaccines and challenges ahead
Kanta Subbarao
Cell Host & Microbe (2021) Vol. 29, Iss. 7, pp. 1111-1123
Open Access | Times Cited: 89
Highly Specific Memory B Cells Generation after the 2nd Dose of BNT162b2 Vaccine Compensate for the Decline of Serum Antibodies and Absence of Mucosal IgA
Eva Piano Mortari, Cristina Russo, M. Vinci, et al.
Cells (2021) Vol. 10, Iss. 10, pp. 2541-2541
Open Access | Times Cited: 72
SARS-CoV-2 variants, immune escape, and countermeasures
Yi Zhang, Haocheng Zhang, Wenhong Zhang
Frontiers of Medicine (2022) Vol. 16, Iss. 2, pp. 196-207
Open Access | Times Cited: 65
Phytochemicals-based targeting RdRp and main protease of SARS-CoV-2 using docking and steered molecular dynamic simulation: A promising therapeutic approach for Tackling COVID-19
Arpana Parihar, Zannatul Ferdous Sonia, Farjana Akter, et al.
Computers in Biology and Medicine (2022) Vol. 145, pp. 105468-105468
Open Access | Times Cited: 53
Host immunological responses facilitate development of SARS-CoV-2 mutations in patients receiving monoclonal antibody treatments
Akshita Gupta, Angelina Konnova, Mathias Smet, et al.
Journal of Clinical Investigation (2023) Vol. 133, Iss. 6
Open Access | Times Cited: 32
Molecular rationale for SARS-CoV-2 spike circulating mutations able to escape bamlanivimab and etesevimab monoclonal antibodies
Erik Laurini, Domenico Marson, Suzana Aulić, et al.
Scientific Reports (2021) Vol. 11, Iss. 1
Open Access | Times Cited: 51
Tracking the circulating SARS-CoV-2 variant of concern in South Africa using wastewater-based epidemiology
Rabia Johnson, Jyoti Sharma, Pritika Ramharack, et al.
Scientific Reports (2022) Vol. 12, Iss. 1
Open Access | Times Cited: 35
B cell analyses after SARS-CoV-2 mRNA third vaccination reveals a hybrid immunity like antibody response
Emanuele Andreano, Ida Paciello, Giulio Pierleoni, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 20
SARS-CoV-2 Spike Protein Mutations and Escape from Antibodies: A Computational Model of Epitope Loss in Variants of Concern
Alice Triveri, Stefano A. Serapian, Filippo Marchetti, et al.
Journal of Chemical Information and Modeling (2021) Vol. 61, Iss. 9, pp. 4687-4700
Open Access | Times Cited: 35
Anatomy of Omicron BA.1 and BA.2 neutralizing antibodies in COVID-19 mRNA vaccinees
Emanuele Andreano, Ida Paciello, Silvia Marchese, et al.
Nature Communications (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 27
Rapid detection of multiple SARS-CoV-2 variants of concern by PAM-targeting mutations
Bo Ning, Brady M. Youngquist, Diane D. Li, et al.
Cell Reports Methods (2022) Vol. 2, Iss. 2, pp. 100173-100173
Open Access | Times Cited: 25
Bacteria-enabled oral delivery of a replicon-based mRNA vaccine candidate protects against ancestral and delta variant SARS-CoV-2
Vijayakumar Jawalagatti, Perumalraja Kirthika, Chamith Hewawaduge, et al.
Molecular Therapy (2022) Vol. 30, Iss. 5, pp. 1926-1940
Open Access | Times Cited: 22
Broad ultra-potent neutralization of SARS-CoV-2 variants by monoclonal antibodies specific to the tip of RBD
Hang Ma, Yingying Guo, Haoneng Tang, et al.
Cell Discovery (2022) Vol. 8, Iss. 1
Open Access | Times Cited: 22
Myocarditis and COVID-19 Mrna Vaccines: A Mechanistic Hypothesis Involving dsRNA
G. Milano, Jocelyn Gal, Anne Creisson, et al.
Future Virology (2021) Vol. 17, Iss. 3, pp. 191-196
Open Access | Times Cited: 28
Development of antibody resistance in emerging mutant strains of SARS CoV‐2: Impediment for COVID‐19 vaccines
Narasimha M. Beeraka, Olga Sukocheva, Elena Lukina, et al.
Reviews in Medical Virology (2022) Vol. 32, Iss. 5
Open Access | Times Cited: 20
Occurrence of a novel cleavage site for cathepsin G adjacent to the polybasic sequence within the proteolytically sensitive activation loop of the SARS-CoV-2 Omicron variant: The amino acid substitution N679K and P681H of the spike protein
Zhadyra Mustafa, Hubert Kalbacher, Timo Burster
PLoS ONE (2022) Vol. 17, Iss. 4, pp. e0264723-e0264723
Open Access | Times Cited: 20
Structural and computational design of a SARS-CoV-2 spike antigen with improved expression and immunogenicity
James A. Williams, Marco Biancucci, Laura N. Lessen, et al.
Science Advances (2023) Vol. 9, Iss. 23
Open Access | Times Cited: 12
Immunoinformatics Study: Multi-Epitope Based Vaccine Design from SARS-CoV-2 Spike Glycoprotein
Ramadhita Umitaibatin, Azza Hanif Harisna, Muhammad Miftah Jauhar, et al.
Vaccines (2023) Vol. 11, Iss. 2, pp. 399-399
Open Access | Times Cited: 11
A Tale of Three Recent Pandemics: Influenza, HIV and SARS-CoV-2
Mafalda Miranda, Marta Pingarilho, Victor Pimentel, et al.
Frontiers in Microbiology (2022) Vol. 13
Open Access | Times Cited: 18
Combination of chemistry and material science to overcome health problems
Johannes Karges
Biosafety and Health (2022) Vol. 4, Iss. 2, pp. 64-65
Open Access | Times Cited: 16
Sustained seropositivity up to 20.5 months after COVID-19
Carlota Dobaño, Anna Ramírez‐Morros, Selena Alonso, et al.
BMC Medicine (2022) Vol. 20, Iss. 1
Open Access | Times Cited: 16
Page 1 - Next Page

Scroll to top